Alkem Laboratories Partners with Takeda to Launch Vonoprazan for Gastroesophageal Reflux Disease in India
Alkem Laboratories Ltd. (BSE: 539523, NSE: ALKEM), a prominent Indian pharmaceutical company has announced a strategic non-exclusive patent licensing agreement […]